Timeline

Marie-Louise Michel

Retired scientist

01 Aug 2023

publication

Integrated analysis of whole blood oxylipin and cytokine responses after bacterial, viral, and T cell stimulation reveals new immune networks.

11 Mar 2023

publication

Rapid protection induced by a single-shot Lassa vaccine in male cynomolgus monkeys.

01 Feb 2023

publication

Antagonism of ALAS1 by the Measles Virus V protein contributes to degradation of the mitochondrial network and promotes interferon response.

01 Dec 2022

publication

Les virus au service de la santé : la vaccination Viruses to rescue health: Vaccination

01 Oct 2022

publication

Respiratory Syncytial Virus NS1 Protein Targets the Transactivator Binding Domain of MED25

15 Jul 2022

publication

Y RNAs are conserved endogenous RIG-I ligands across RNA virus infection and are targeted by HIV-1.

24 May 2022

publication

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

15 Apr 2022

publication

Rhesus negative males have an enhanced IFNγ-mediated immune response to influenza A virus.

22 Dec 2021

publication

sgDI-tector: defective interfering viral genome bioinformatics for detection of coronavirus subgenomic RNAs

01 Dec 2021

publication

A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters.

27 Sep 2021

publication

HIV-1 hijacks the cell extracellular matrix to spread collectively and efficiently between T lymphocytes

09 Sep 2021

course

MOOC Viruses and Human Cancers

01 Sep 2021

publication

Discovery of genes that modulate flavivirus replication in an interferon-dependent manner

27 Jan 2021

publication

Proteomic Analysis Uncovers Measles Virus Protein C Interaction With p65-iASPP Protein Complex.

27 Oct 2020

publication

Retinoic Acid Inducible Gene I and Protein Kinase R, but Not Stress Granules, Mediate the Proinflammatory Response to Yellow Fever Virus

13 Jan 2020

publication

Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus.

01 Jan 2020

publication

Reply to: Oncolytic Viral Therapy for Malignant Pleural Mesothelioma

01 Jan 2019

publication

Evaluation of the Antiviral Activity of Sephin1 Treatment and Its Consequences on eIF2α Phosphorylation in Response to Viral Infections

06 Aug 2015

publication

Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial

23 Jul 2015

publication

Recognition of core-derived epitopes from a novel HBV-targeted immunotherapeutic by T-cells from patients infected by different viral genotypes

02 Jul 2015

publication

HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase

10 Feb 2015

publication

Towards an HBV cure: state-of-the-art and unresolved questions–report of the ANRS workshop on HBV cure

01 Jan 2015

publication

Minicircle: Next Generation DNA Vectors for Vaccination

16 Dec 2014

publication

Therapeutic vaccines in treating chronic hepatitis B: the end of the beginning or the beginning of the end?

26 Nov 2014

publication

TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice

27 Jun 2014

publication

Human hematopoietic reconstitution and HLA-restricted responses in nonpermissive alymphoid mice

20 Mar 2014

publication

Functional analysis via standardized whole-blood stimulation systems defines the boundaries of a healthy immune response to complex stimuli.

19 Mar 2014

publication

Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection

03 Feb 2014

publication

In Vitro Activities of Dermaseptins K4S4 and K4K20S4 against Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa Planktonic Growth and Biofilm Formation

29 Jan 2014

publication

Large-Scale Nucleotide Optimization of Simian Immunodeficiency Virus Reduces Its Capacity To Stimulate Type I Interferon In Vitro

26 Dec 2013

publication

Adenoviral delivery of recombinant hepatitis B virus expressing foreign antigenic epitopes for immunotherapy of persistent viral infection

06 Mar 2013

publication

Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules

15 May 2012

publication

Optimization of immune responses induced by therapeutic vaccination with cross-reactive antigens in a humanized hepatitis B surface antigen transgenic mouse model

20 Jul 2011

publication

Plasmid vector-linked maturation of natural killer (NK) cells is coupled to antigen-dependent NK cell activation during DNA-based immunization in mice

14 Jan 2011

publication

Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: perspectives and challenges

31 Mar 2010

publication

Hepatitis B virus (HBV)-derived DRB1*0101-restricted CD4 T-cell epitopes help in the development of HBV-specific CD8+ T cells in vivo

18 Jan 2010

publication

Changes to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccination

08 Dec 2009

publication

ViralORFeome: an integrated database to generate a versatile collection of viral ORFs.

01 Nov 2009

publication

Hepatitis B virus as a gene delivery vector activating foreign antigenic T cell response that abrogates viral expression in mouse models

01 Oct 2009

publication

Sequence analysis of the large (L) polymerase gene and trailer of the peste des petits ruminants virus vaccine strain Nigeria 75/1: expression and use of the L protein in reverse genetics.

14 Mar 2007

publication

Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients

12 Sep 2006

publication

Identification of novel HLA-DR1-restricted epitopes from the hepatitis B virus envelope protein in mice expressing HLA-DR1 and vaccinated human subjects

01 Dec 2005

publication

Therapeutic vaccination against chronic hepatitis B virus infection

18 Aug 2005

publication

Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers

20 May 2005

publication

Loss of reactivity of vaccine-induced CD4 T cells in immunized monkeys after SIV/HIV challenge

01 May 2005

publication

[Therapeutic vaccination against chronic hepatitis B virus infection]

16 Mar 2005

publication

In vivo hierarchy of immunodominant and subdominant HLA-A*0201-restricted T-cell epitopes of HBx antigen of hepatitis B virus

01 Jan 2005

publication

In vivo induction of cellular and humoral immune responses by hybrid DNA vectors encoding simian/human immunodeficiency virus/hepatitis B surface antigen virus particles in BALB/c and HLA-A2-transgenic mice

15 Dec 2004

publication

A chimeric human T cell leukemia virus type I bearing a deltaR Moloney-murine leukemia virus envelope infects mice persistently and induces humoral and cellular immune responses.

01 Nov 2004

publication

A mouse model of human adaptive immune functions: HLA-A2.1-/HLA-DR1-transgenic H-2 class I-/class II-knockout mice

01 Oct 2004

publication

Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers

01 Sep 2004

publication

Efficient priming of simian/human immunodeficiency virus (SHIV)-specific T-cell responses with DNA encoding hybrid SHIV/hepatitis B surface antigen particles

12 Jul 2004

publication

Comparison of HLA-DR1-restricted T cell response induced in HLA-DR1 transgenic mice deficient for murine MHC class II and HLA-DR1 transgenic mice expressing endogenous murine MHC class II molecules

01 Oct 2003

publication

A little guide for advanced search:

Integrated analysis of whole blood oxylipin and cytokine responses after bacterial, viral, and T cell stimulation reveals new immune networks.

Rapid protection induced by a single-shot Lassa vaccine in male cynomolgus monkeys.

Antagonism of ALAS1 by the Measles Virus V protein contributes to degradation of the mitochondrial network and promotes interferon response.

Les virus au service de la santé : la vaccination Viruses to rescue health: Vaccination

Respiratory Syncytial Virus NS1 Protein Targets the Transactivator Binding Domain of MED25

Y RNAs are conserved endogenous RIG-I ligands across RNA virus infection and are targeted by HIV-1.

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

Rhesus negative males have an enhanced IFNγ-mediated immune response to influenza A virus.

sgDI-tector: defective interfering viral genome bioinformatics for detection of coronavirus subgenomic RNAs

A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters.

HIV-1 hijacks the cell extracellular matrix to spread collectively and efficiently between T lymphocytes

MOOC Viruses and Human Cancers

Discovery of genes that modulate flavivirus replication in an interferon-dependent manner

Proteomic Analysis Uncovers Measles Virus Protein C Interaction With p65-iASPP Protein Complex.

Retinoic Acid Inducible Gene I and Protein Kinase R, but Not Stress Granules, Mediate the Proinflammatory Response to Yellow Fever Virus

Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus.

Reply to: Oncolytic Viral Therapy for Malignant Pleural Mesothelioma

Evaluation of the Antiviral Activity of Sephin1 Treatment and Its Consequences on eIF2α Phosphorylation in Response to Viral Infections

Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial

Recognition of core-derived epitopes from a novel HBV-targeted immunotherapeutic by T-cells from patients infected by different viral genotypes

HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase

Towards an HBV cure: state-of-the-art and unresolved questions–report of the ANRS workshop on HBV cure

Minicircle: Next Generation DNA Vectors for Vaccination

Therapeutic vaccines in treating chronic hepatitis B: the end of the beginning or the beginning of the end?

TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice

Human hematopoietic reconstitution and HLA-restricted responses in nonpermissive alymphoid mice

Functional analysis via standardized whole-blood stimulation systems defines the boundaries of a healthy immune response to complex stimuli.

Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection

In Vitro Activities of Dermaseptins K4S4 and K4K20S4 against Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa Planktonic Growth and Biofilm Formation

Large-Scale Nucleotide Optimization of Simian Immunodeficiency Virus Reduces Its Capacity To Stimulate Type I Interferon In Vitro

Adenoviral delivery of recombinant hepatitis B virus expressing foreign antigenic epitopes for immunotherapy of persistent viral infection

Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules

Optimization of immune responses induced by therapeutic vaccination with cross-reactive antigens in a humanized hepatitis B surface antigen transgenic mouse model

Plasmid vector-linked maturation of natural killer (NK) cells is coupled to antigen-dependent NK cell activation during DNA-based immunization in mice

Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: perspectives and challenges

Hepatitis B virus (HBV)-derived DRB1*0101-restricted CD4 T-cell epitopes help in the development of HBV-specific CD8+ T cells in vivo

Changes to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccination

ViralORFeome: an integrated database to generate a versatile collection of viral ORFs.

Hepatitis B virus as a gene delivery vector activating foreign antigenic T cell response that abrogates viral expression in mouse models

Sequence analysis of the large (L) polymerase gene and trailer of the peste des petits ruminants virus vaccine strain Nigeria 75/1: expression and use of the L protein in reverse genetics.

Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients

Identification of novel HLA-DR1-restricted epitopes from the hepatitis B virus envelope protein in mice expressing HLA-DR1 and vaccinated human subjects

Therapeutic vaccination against chronic hepatitis B virus infection

Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers

Loss of reactivity of vaccine-induced CD4 T cells in immunized monkeys after SIV/HIV challenge

[Therapeutic vaccination against chronic hepatitis B virus infection]

In vivo hierarchy of immunodominant and subdominant HLA-A*0201-restricted T-cell epitopes of HBx antigen of hepatitis B virus

In vivo induction of cellular and humoral immune responses by hybrid DNA vectors encoding simian/human immunodeficiency virus/hepatitis B surface antigen virus particles in BALB/c and HLA-A2-transgenic mice

A chimeric human T cell leukemia virus type I bearing a deltaR Moloney-murine leukemia virus envelope infects mice persistently and induces humoral and cellular immune responses.

A mouse model of human adaptive immune functions: HLA-A2.1-/HLA-DR1-transgenic H-2 class I-/class II-knockout mice

Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers

Efficient priming of simian/human immunodeficiency virus (SHIV)-specific T-cell responses with DNA encoding hybrid SHIV/hepatitis B surface antigen particles

Comparison of HLA-DR1-restricted T cell response induced in HLA-DR1 transgenic mice deficient for murine MHC class II and HLA-DR1 transgenic mice expressing endogenous murine MHC class II molecules

New gene-based approaches for an AIDS vaccine